The U.S. Patent and Trademark Office has announced the agenda for the next biotechnology/chemical/ pharmaceutical (BCP) customer partnership meeting to be held on March 6, 2012. The proposed agenda is as follows:
Morning Session
• Meet & Greet and Opening Remarks (9:30 - 10:00 am ET): George Elliott, Wanda Walker, and Dan Sullivan (Acting), Directors, Technology Center 1600
• Lead Compound CAFC Obviousness Analysis (10:00 - 11:00 am): Joseph Mallon, Knobbe Martens Olson & Bear LLP
• Break (11:00 - 11:15 am)
• Native American Herbal Medicines (11:15 am - 12:15 pm): Patricia Leith, Primary Examiner, Art Unit 1655
• Lunch (12:15 – 1:30 pm)
Afternoon Session
• Response to Applicant's Argument (Workshop) (1:30 - 2:30 pm): Kathleen Bragdon, QAS, TC 1600
• Break (2:30 - 2:45 pm)
• TC1600 Specific KSR Examples (2:45 - 3:45 pm): Jean Witz, QAS, TC1600
• Closing Remarks/Discussion (3:45 - 4:00 pm): George Elliott, Wanda Walker, and Dan Sullivan (Acting), Directors, Technology Center 1600
The meeting can be attended in person at the USPTO's Madison Auditorium, 600 Dulany Street, Alexandria, VA, or viewed online here (select the "enter as guest" option). The Patent Office asks that non-USPTO employees login using their e-mail addresses. Those wishing to attend the meeting should contact Cecilia Tsang by phone at 571-272-0562, by fax at 571-273-0562, or by e-mail at [email protected] by February 27, 2012 to confirm their attendance. Additional information regarding the BCP customer partnership meeting can be found here.
Comments